Dr. Shvetank Bhatt

Bio

Dr. Shvetank Bhatt is an Associate Professor at the School of Science and Technology, MIT World Peace University (MIT-WPU), with over 15 years of experience in teaching and research and 4 years of industry experience. He has previously served at BITS Pilani (Pilani Campus), Ramaiah University of Applied Sciences, Bengaluru, and Amity University Madhya Pradesh, Gwalior, and has worked in industries including Ranbaxy Research Laboratories, Gurugram, Microtherapeutic Research Labs, Chennai, and Smart Analyst India Pvt. Ltd., Gurugram.

He completed his B.Pharm from the University of Rajasthan, Jaipur, M.Pharm in Pharmacology from the Manipal Academy of Higher Education (MAHE), Manipal, and Ph.D. in Pharmaceutical Sciences from BITS Pilani, Pilani Campus, Rajasthan. His research focuses on neuropharmacology, particularly depression, anxiety, Alzheimer’s disease, and other CNS disorders.

Dr. Bhatt has authored over 100 research publications, 7 books, and 40 book chapters, and has completed one UGC-funded project and five industry-sponsored projects. He holds two Indian patents and one Australian patent. His research impact includes 2,829 citations, an h-index of 24, and an i10-index of 54. He is listed among the Top 2% Scientists globally (Stanford–Elsevier, 2024 & 2025), has received over 10 awards, and serves as an editor and reviewer for leading international journals. He is a life member of the Association of Pharmaceutical Teachers of India (APTI) and the Indian Pharmacological Society (IPS).

Educational Qualifications
M. Pharm, PhD

Research Area
Neuropharmacology, CNS dis, Pharmacokinetics and Toxicology

Recent Publications

Keswani R, Thorat VG, Patil CR, Bhatt S. Exploring the role of adipocytokines in obesity associated depression. Drug Discov Today. 2025;30(12):104509. (Elsevier) (IF: 7.5)

Marathe CK, Thorat VG, Kokate IP, Pawar AT, Bhatt S. Antidepressant- and anxiolytic-like effects of linezolid in streptozotocin-induced diabetic mice via modulation of brain serotonin and plasma corticosterone activity. Biochem Biophys Res Commun. 2025;765:151843. (Elsevier) (IF: 2.2)

Tomar Y, Baidya M, Chadokiya J, Bhatt S, Singhvi G. An overview of Skp2: a promising new therapeutic target of psoriasis. Expert Opin Ther Targets. 2024; 5:1-12. (Taylor & Francis) (IF: 4.6).

Gangarde P, Bhatt S, Pujari R. Assessment of neuroprotective potential of Cuscuta reflexa in aluminium chloride-induced experimental model of Alzheimer's disease: In vitro and in vivo studies. J Trace Elem Med Biol. 2025;88:127612. (Elsevier) (IF: 3.3).

Anitha K, Singh MK, Kohat K, Sri Varshini T, Chenchula S, Padmavathi R, Amerneni LS, Vishnu Vardhan K, Mythili Bai K, Chavan MR, Bhatt S. Recent Insights into the Neurobiology of Alzheimer's Disease and Advanced Treatment Strategies. Mol Neurobiol. 2025;62(2):2314-2332. (Springer) (IF: 4.3)

Google Scholar Link
https://scholar.google.com/citations?user=sWVSgIwAAAAJ&hl=en

Scopus Author ID Link
https://www.scopus.com/authid/detail.uri?authorId=57197493015

Orcid Link
https://orcid.org/0000-0001-8696-3462